Nektar Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Insights

Nektar Therapeutics (NKTR)

70.37 +1.95 (+2.85%) USD | NASDAQ | Feb 25, 16:00

70.37 0.00 (0.00%) After-Hours: 16:21

View Preferred Securities out of Shareholders Equity (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	--
Insmed, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Ironwood Pharmaceuticals, Inc.	--
Lyell Immunopharma, Inc.	--